174 related articles for article (PubMed ID: 30467026)
1. Targeting the Pentose Phosphate Pathway: Characterization of a New 6PGL Inhibitor.
Tran AT; Sadet A; Calligari P; Lopes P; Ouazzani J; Sollogoub M; Miclet E; Abergel D
Biophys J; 2018 Dec; 115(11):2114-2126. PubMed ID: 30467026
[TBL] [Abstract][Full Text] [Related]
2. Insights into the enzymatic mechanism of 6-phosphogluconolactonase from Trypanosoma brucei using structural data and molecular dynamics simulation.
Duclert-Savatier N; Poggi L; Miclet E; Lopes P; Ouazzani J; Chevalier N; Nilges M; Delarue M; Stoven V
J Mol Biol; 2009 May; 388(5):1009-21. PubMed ID: 19345229
[TBL] [Abstract][Full Text] [Related]
3. Three dimensional structure and implications for the catalytic mechanism of 6-phosphogluconolactonase from Trypanosoma brucei.
Delarue M; Duclert-Savatier N; Miclet E; Haouz A; Giganti D; Ouazzani J; Lopez P; Nilges M; Stoven V
J Mol Biol; 2007 Feb; 366(3):868-81. PubMed ID: 17196981
[TBL] [Abstract][Full Text] [Related]
4. 6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomes.
Hanau S; Rinaldi E; Dallocchio F; Gilbert IH; Dardonville C; Adams MJ; Gover S; Barrett MP
Curr Med Chem; 2004 Oct; 11(19):2639-50. PubMed ID: 15544466
[TBL] [Abstract][Full Text] [Related]
5. Thermodynamic characterization of substrate and inhibitor binding to Trypanosoma brucei 6-phosphogluconate dehydrogenase.
Montin K; Cervellati C; Dallocchio F; Hanau S
FEBS J; 2007 Dec; 274(24):6426-35. PubMed ID: 18021252
[TBL] [Abstract][Full Text] [Related]
6. The enzymes of the classical pentose phosphate pathway display differential activities in procyclic and bloodstream forms of Trypanosoma brucei.
CronÃn CN; Nolan DP; Voorheis HP
FEBS Lett; 1989 Feb; 244(1):26-30. PubMed ID: 2924907
[TBL] [Abstract][Full Text] [Related]
7. Evidence for dimer/tetramer equilibrium in Trypanosoma brucei 6-phosphogluconate dehydrogenase.
Hanau S; d'Empaire LP; Capone I; Alberighi S; Montioli R; Dallocchio F
Biochim Biophys Acta; 2013 Dec; 1834(12):2647-52. PubMed ID: 24096100
[TBL] [Abstract][Full Text] [Related]
8. The pentose phosphate pathway in Trypanosoma cruzi.
Maugeri DA; Cazzulo JJ
FEMS Microbiol Lett; 2004 May; 234(1):117-23. PubMed ID: 15109729
[TBL] [Abstract][Full Text] [Related]
9. Molecular explorations of the Leishmania donovani 6-phosphogluconolactonase enzyme, a key player in the pentose phosphate pathway.
Dhumal TT; Kumar R; Paul A; Roy PK; Garg P; Singh S
Biochimie; 2022 Nov; 202():212-225. PubMed ID: 36037881
[TBL] [Abstract][Full Text] [Related]
10. 6-Phosphogluconate dehydrogenase from Trypanosoma brucei. Kinetic analysis and inhibition by trypanocidal drugs.
Hanau S; Rippa M; Bertelli M; Dallocchio F; Barrett MP
Eur J Biochem; 1996 Sep; 240(3):592-9. PubMed ID: 8856059
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of the first two enzymes of the pentose-phosphate pathway of Trypanosoma brucei. Glucose-6-phosphate dehydrogenase and 6-phosphogluconolactonase.
Duffieux F; Van Roy J; Michels PA; Opperdoes FR
J Biol Chem; 2000 Sep; 275(36):27559-65. PubMed ID: 10867008
[TBL] [Abstract][Full Text] [Related]
12. Virtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase.
Ruda GF; Campbell G; Alibu VP; Barrett MP; Brenk R; Gilbert IH
Bioorg Med Chem; 2010 Jul; 18(14):5056-62. PubMed ID: 20598892
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of substrate-based inhibitors of 6-phosphogluconate dehydrogenase as potential drugs against African trypanosomiasis.
Dardonville C; Rinaldi E; Hanau S; Barrett MP; Brun R; Gilbert IH
Bioorg Med Chem; 2003 Jul; 11(14):3205-14. PubMed ID: 12818683
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of phosphate prodrugs of 4-phospho-D-erythronohydroxamic acid, an inhibitor of 6-phosphogluconate dehydrogenase.
Ruda GF; Alibu VP; Mitsos C; Bidet O; Kaiser M; Brun R; Barrett MP; Gilbert IH
ChemMedChem; 2007 Aug; 2(8):1169-80. PubMed ID: 17615587
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of 6-phosphogluconate dehydrogenase from Trypanosoma brucei.
Bertelli M; El-Bastawissy E; Knaggs MH; Barrett MP; Hanau S; Gilbert IH
J Comput Aided Mol Des; 2001 May; 15(5):465-75. PubMed ID: 11394739
[TBL] [Abstract][Full Text] [Related]
16. The 6-phosphogluconate dehydrogenase from Trypanosoma cruzi: the absence of two inter-subunit salt bridges as a reason for enzyme instability.
Esteve MI; Cazzulo JJ
Mol Biochem Parasitol; 2004 Feb; 133(2):197-207. PubMed ID: 14698432
[TBL] [Abstract][Full Text] [Related]
17. Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer.
Choi J; Kim ES; Koo JS
Dis Markers; 2018; 2018():9369358. PubMed ID: 29682102
[TBL] [Abstract][Full Text] [Related]
18. 6-Phosphogluconate dehydrogenase: the mechanism of action investigated by a comparison of the enzyme from different species.
Rippa M; Giovannini PP; Barrett MP; Dallocchio F; Hanau S
Biochim Biophys Acta; 1998 Dec; 1429(1):83-92. PubMed ID: 9920387
[TBL] [Abstract][Full Text] [Related]
19. A 2.8 A resolution structure of 6-phosphogluconate dehydrogenase from the protozoan parasite Trypanosoma brucei: comparison with the sheep enzyme accounts for differences in activity with coenzyme and substrate analogues.
Phillips C; Dohnalek J; Gover S; Barrett MP; Adams MJ
J Mol Biol; 1998 Sep; 282(3):667-81. PubMed ID: 9737929
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high-energy intermediate and transition-state analogues.
Dardonville C; Rinaldi E; Barrett MP; Brun R; Gilbert IH; Hanau S
J Med Chem; 2004 Jun; 47(13):3427-37. PubMed ID: 15189039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
